rareLife solutions is Dan’s second software and service focused venture. Having observed the often fractured, though always passionate stakeholders in rare diseases, Dan was inspired to create onevoice, providing rare disease-specific “guided communities” thoughtfully designed to address several unmet needs while improving disease understanding and accelerating research. Dan’s immersion into rare diseases began in 2011 when he was appointed to the Board of Directors and later as Chief Business Officer of Cancer Prevention Pharmaceuticals (CPP). It was through his involvement with CPP that Dan discovered how incredibly fractured rare disease communities tend to be and he felt there had to be a better way to help these communities who needed help the most.
Prior to rareLife and CPP, Dan founded Envision Pharma in 2001, serving as President through June 2011. Dan was the visionary behind the creation and development of Datavision, the market leader in medical publications technology. Envision Pharma was acquired by the United BioSource Corporation (UBC) in April 2008. At UBC, Dan was Senior Vice President, Strategy and Market Development and a member of the Leadership Team. Dan cut his teeth in the industry at Pfizer serving in a variety of positions of increasing responsibility, ranging from sales to market research and marketing in the US domestic and international market place, culminating in his position as Director and European Team Leader for the world's largest cardiovascular portfolio, living in Belgium. During his time at Pfizer, he played a pivotal role in the commercialization of some of the pharmaceutical industry's most successful product launches.
Dan lectures frequently at specialty industry conferences and webinars, most recently at “Patients as Partners” in Philadelphia where he discussed Building a Digital Home.
rareLife solutions specializes in 3 elements critical to the successful development of treatments for rare diseases: collaboration, science and technology. We offer integrated consulting services and software and platform as a service solutions for advocacy groups, pharmaceutical and device companies, medical and research centers, and professional healthcare associations. Our community building technology - onevoice.world - is customized with the guidance of patients, advocates and caregivers from the community for which the platform serves - see www.onescdvoice.com developed by and for the sickle cell community.We look for the solution where it may not already exist, we build things to fill voids, we listen, watch and learn for insights and opportunities to truly be of service to people impacted by rare disease. We vision new ideas (the easy part) and roll up our sleeves to implement them (the really hard part). We collaborate and join forces with those companies, institutions and organizations who are also seeking better treatments and services for the historically underserved rare disease communities.